Authors: MITCHELL GA KASSOVSKABRATINOVA S BOUKAFTANE Y ROBERT MF WANG SP ASHMARINA L LAMBERT M LAPIERRE P POTIER E

Citation: Ga. Mitchell et al., MEDICAL ASPECTS OF KETONE-BODY METABOLISM, Clinical and investigative medicine, 18(3), 1995, pp. 193-216

Authors: SISTO A BONELLI F CENTINI F FINCHAM CI POTIER E MONTEAGUDO E LOMBARDI P ARCAMONE F GOSO C MANZINI S GIOLITTI A MAGGI CA VENANZI M PISPISA B

Citation: A. Sisto et al., SYNTHESIS AND BIOLOGICAL EVALUATION OF NOVEL NK-1 TACHYKININ RECEPTORANTAGONISTS - THE USE OF CYCLOALKYL AMINO-ACIDS AS A TEMPLATE, Biopolymers, 36(4), 1995, pp. 511-524

Authors: GOSO C POTIER E MANZINI S SZALLASI A

Citation: C. Goso et al., COMPARISON OF TACHYKININ NK(1) RECEPTORS IN HUMAN IM9 AND U373-MG CELLS, USING ANTAGONIST (FK888, (PLUS-OR-MINUS)-CP-96,345, AND RP-67580) BINDING, European journal of pharmacology, 254(3), 1994, pp. 221-227

Authors: MAGGI CA PATACCHINI R MEINI S QUARTARA L SISTO A POTIER E GIULIANI S GIACHETTI A

Citation: Ca. Maggi et al., COMPARISON OF TACHYKININ NK1 AND NK2 RECEPTORS IN THE CIRCULAR MUSCLEOF THE GUINEA-PIG ILEUM AND PROXIMAL COLON, British Journal of Pharmacology, 112(1), 1994, pp. 150-160